Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.8.0.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]    
Revenues
Operating expenses:    
Research and development 2,680,983 1,292,780
General and administrative 913,088 940,089
Total operating expenses 3,594,071 2,232,869
Operating loss (3,594,071) (2,232,869)
Other income (expense):    
Interest income 10,960 2,163
Interest expense (1,409) (1,345)
Amortization of debt discount and offering costs (2,065) (59)
Total other income 7,486 759
Net loss $ (3,586,585) $ (2,232,110)
Basic and diluted net loss per share $ (0.09) $ (0.06)
Weighted average common shares outstanding - basic and diluted 39,674,563 35,788,158